Substance without an audience: strong current business reported into a thin, shallow professional crowd
The model's full reasoning — Q2 2023 call → NOWe need to evaluate the transcript for both conditions: (1) genuinely strong, concrete current business operating strength, and (2) thin or shallow professional audience engagement. First, check for strong current operating substance. The transcript mentions: "thousands of patients who have been dosed with AAV therapeutics derived from our proprietary NAV technology platform" and "hundreds more receiving treatment every quarter." Also "approximately two children per day are receiving ZOLGENSMA" which uses their vector. They mention "over 12 active clinical trials" and "one new patient is being dosed in REGENXBIO clinical trials daily." They also mention "two pivotal phase programs that include over 1,000 subjects" and plans to file BLA in 2024-2025. However, these are mostly about clinical trials and pipeline. The question asks for "real, present-tense operating strength" such as growing orders, customers, volumes, output, utilization, wins, deployments, or activity. The company is a biotech, so "operating strength" might be about clinical trial progress, patient dosing, manufacturing, etc. They mention "manufacturing innovation center here in Rockville running scalable commercial-ready batches of AAV Therapeutics" and "product quality and yield" data presented at Investor Day. They also mention "completed enrollment of 10 patients for CAMPSIITE trial" and "completed enrollment of the Phase 1/2 trial" for RGX-111. They also mention "recent dosing of our first patient with RGX-381." So there is concrete activity: patient dosing, trial enrollment, manufacturing. But is it "strong" and "current"? They are reporting progress, but it's not like they have revenue or commercial sales. The question says "such as growing orders, customers, volumes, output, utilization, wins, deployments, or activity" - activity could be clinical trial activity. They are dosing patients daily, enrolling trials, etc. That seems concrete and current. They also mention "we are conducting over 12 active clinical trials" and "one new patient is being dosed daily." That is specific. Also they have a partnership with AbbVie and are advancing programs. So I think there is genuine current operating strength in terms of clinical development activity. Now check the Q&A engagement.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| SNCR | Synchronoss Technologies, Inc. | Q1 2024 | 2024-05-07 | C+ |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| LUNG | Pulmonx Corporation | Q1 2024 | 2024-05-01 | B+ |
| CERS | Cerus Corporation | Q4 2023 | 2024-03-05 | B+ |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| CHT | Chunghwa Telecom Co., Ltd. | Q4 2023 | 2024-01-30 | C |
| CSPI | CSP Inc. | Q4 2023 | 2023-12-12 | D |
| AWH | Aspira Women's Health Inc. | Q3 2023 | 2023-11-13 | D |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| SWKH | SWK Holdings Corporation | Q3 2023 | 2023-11-09 | B |
| JXN | Jackson Financial Inc. | Q3 2023 | 2023-11-09 | C |
| NFG | National Fuel Gas Company | Q4 2023 | 2023-11-02 | B+ |
| FSBC | Five Star Bancorp | Q3 2023 | 2023-10-31 | B |
| PTN | Palatin Technologies, Inc. | Q4 2023 | 2023-09-29 | D |
| KMDA | Kamada Ltd. | Q2 2023 | 2023-08-16 | B+ |
| ZOM | Zomedica Corp. | Q2 2023 | 2023-08-10 | C |
| ATIP | ATI Physical Therapy, Inc. | Q2 2023 | 2023-08-07 | C+ |
| INTT | inTEST Corporation | Q2 2023 | 2023-08-04 | A |
| BLX | Banco Latinoamericano de Comercio Exteri | Q2 2023 | 2023-07-21 | B |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SLDP | Solid Power, Inc. | Q1 2023 | 2023-05-08 | C+ |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| NCSM | NCS Multistage Holdings, Inc. | Q4 2022 | 2023-03-07 | A |
| AAOI | Applied Optoelectronics, Inc. | Q4 2022 | 2023-02-23 | C |
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| CNA | CNA Financial Corporation | Q4 2022 | 2023-02-06 | B |
| CIG | Companhia Energética de Minas Gerais | Q3 2022 | 2022-11-16 | C+ |
| FET | Forum Energy Technologies, Inc. | Q3 2022 | 2022-11-09 | B |
| DAC | Danaos Corporation | Q3 2022 | 2022-11-08 | B+ |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| AFG | American Financial Group, Inc. | Q3 2022 | 2022-11-04 | B+ |
| PLOW | Douglas Dynamics, Inc. | Q3 2022 | 2022-11-01 | B+ |
| AYTU | Aytu BioPharma, Inc. | Q4 2022 | 2022-09-27 | C |
| APOG | Apogee Enterprises, Inc. | Q2 2023 | 2022-09-20 | A |
| DM | Desktop Metal, Inc. | Q2 2022 | 2022-08-08 | F |
| BGSF | BGSF, Inc. | Q2 2022 | 2022-08-07 | B+ |
| BBSI | Barrett Business Services, Inc. | Q2 2022 | 2022-08-06 | A |
| XMTR | Xometry, Inc. | Q1 2022 | 2022-05-11 | B+ |
| FARM | Farmer Bros. Co. | Q3 2022 | 2022-05-07 | D |
| FLGT | Fulgent Genetics, Inc. | Q1 2022 | 2022-05-03 | B |
| SILC | Silicom Ltd. | Q1 2022 | 2022-04-30 | B+ |
| CTS | CTS Corporation | Q1 2022 | 2022-04-28 | B |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| CNXC | Concentrix Corporation | Q1 2022 | 2022-03-30 | B |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| REAX | The Real Brokerage Inc. | Q4 2021 | 2022-03-18 | C+ |
| GORO | Gold Resource Corporation | Q4 2021 | 2022-03-11 | B |
| CDMO | Avid Bioservices, Inc. | Q3 2022 | 2022-03-08 | B+ |
| NMRK | Newmark Group, Inc. | Q4 2021 | 2022-02-11 | C+ |
| FFIC | Flushing Financial Corporation | Q4 2021 | 2022-01-28 | B |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| NGS | Natural Gas Services Group, Inc. | Q3 2021 | 2021-11-11 | B+ |
| BGFV | Big 5 Sporting Goods Corporation | Q3 2021 | 2021-11-02 | C+ |
| ZIM | ZIM Integrated Shipping Services Ltd. | Q2 2021 | 2021-08-18 | B+ |
| EGY | VAALCO Energy, Inc. | Q2 2021 | 2021-08-12 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| CPRX | Catalyst Pharmaceuticals, Inc. | Q2 2021 | 2021-08-10 | C+ |
| AMC | AMC Entertainment Holdings, Inc. | Q2 2021 | 2021-08-09 | D |
| HSON | Hudson Global, Inc. | Q2 2021 | 2021-08-08 | B+ |
| UFI | Unifi, Inc. | Q4 2021 | 2021-08-07 | B |
| CRS | Carpenter Technology Corporation | Q4 2021 | 2021-08-01 | A |
| GECC | Great Elm Capital Corporation | Q3 2018 | 2018-11-13 | B |
| VPG | Vishay Precision Group, Inc. | Q3 2018 | 2018-11-11 | B |
| OGE | OGE Energy Corp. | Q3 2018 | 2018-11-08 | A |
| MYO | Myomo, Inc. | Q3 2018 | 2018-11-05 | C |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| AUDC | AudioCodes Ltd. | Q3 2018 | 2018-10-23 | A |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| AU | AngloGold Ashanti's | Q2 2018 | 2018-08-20 | B |
| SRDX | Surmodics, Inc. | Q3 2018 | 2018-08-06 | A |
| SAND | Sandstorm Gold Ltd. | Q1 2018 | 2018-08-02 | B |
| NOVT | Novanta Inc. | Q4 2017 | 2018-05-12 | B+ |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| IDA | IDACORP, Inc. | Q4 2017 | 2018-02-22 | A |
| DLHC | DLH Holdings Corp. | Q1 2018 | 2018-02-06 | C+ |
| TRNS | Transcat, Inc. | Q3 2018 | 2018-01-30 | B+ |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| SBFG | SB Financial Group, Inc. | Q3 2017 | 2017-10-20 | A |
| USAC | USA Compression Partners, LP | Q2 2017 | 2017-08-04 | C+ |
| TPB | Turning Point Brands, Inc. | Q1 2017 | 2017-05-11 | B |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| CECO | CECO Environmental Corp. | Q1 2017 | 2017-05-03 | C+ |
| CGNT | Cognyte Software Ltd. | Q4 2016 | 2017-03-09 | D |
| EVBN | Evans Bancorp, Inc. | Q4 2016 | 2017-02-06 | B+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| ADUS | Addus HomeCare Corporation | Q3 2016 | 2016-11-08 | B |
| LWAY | Lifeway Foods, Inc. | Q2 2016 | 2016-08-17 | C |
| CHDN | Churchill Downs Incorporated | Q2 2016 | 2016-08-04 | C+ |
| ORA | Ormat Technologies, Inc. | Q2 2016 | 2016-08-03 | B+ |
| GEO | The GEO Group, Inc. | Q2 2016 | 2016-08-02 | B+ |
| MRCY | Mercury Systems, Inc. | Q4 2016 | 2016-08-02 | B |
| TPVG | TriplePoint Venture Growth | Q1 2016 | 2016-05-09 | C |
| CSV | Carriage Services, Inc. | Q4 2015 | 2016-02-17 | C+ |
BLX · Q2 2023 → YESThe question requires determining if the earnings call shows BOTH genuinely strong current business AND a thin/shallow professional audience. NO The transcript shows genuinely strong, concrete current business performance with specific metrics like record NII, NIM growth, deposit growth, and commercial portfolio expansion.
RDCM · Q4 2023 → YESThe question requires determining if the earnings call shows BOTH genuinely strong, concrete current business AND a thin or shallow professional audience.
CHT · Q4 2023 → YESThe question requires determining if the earnings call shows BOTH genuinely strong, concrete current business AND a thin or shallow professional audience.